Krystal Biotech, Inc. - Common Stock — キャッシュフロー (NASDAQ:KRYS) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -26.08 M-47.94 M-100.57 M-88.8 M123.42 M200.87 M 250.28 M 投資活動によるキャッシュフロー -11.18 M-226.77 M-114.08 M82.64 M-163.44 M-58.42 M -67.23 M 財務活動によるキャッシュフロー 118.02 M347.69 M35.35 M202.75 M27.01 M8.71 M 10.71 M フリーキャッシュフロー -26.08 M-47.94 M-100.57 M-88.8 M123.42 M188.91 M 237.38 M

ニュース

Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock

Krystal Biotech, Inc. (KRYS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

This Profitable Biotech Stealthily Climbs Into A Buy Zone

Krystal Biotech: Vyjuvek Is Not The Primary Asset (NASDAQ:KRYS)

Rocket Lab Soars 34%, Leads 10 Hot Prospects To IBD Best Stock Screens

Krystal Biotech, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:KRYS) 2026-05-06

Krystal Biotech Analysts Boost Their Forecasts Following Upbeat Q1 Results - Krystal Biotech (NASDAQ:KRYS

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

Krystal Biotech, Inc. (KRYS) Tops Q1 Earnings and Revenue Estimates

Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates

Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth

Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release